FKBP5 and Anxiety: Further strengthening the idea that the early pain burden could serve as a predictor of late emotional outcomes, FKBP51 inhibition during disease onset not only permanently blunted MIA-induced allodynia, as observed in a trauma-induced pain model (6), but also substantially reduced late anhedonia and anxiety-like behavior.